| Kimberly Winship Winship, LCSW-C | |
|
6 Gilland Ct, Nottingham, MD 21236-2901 | |
| (410) 746-5671 | |
| Not Available |
| Full Name | Kimberly Winship Winship |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 23 Years |
| Location | 6 Gilland Ct, Nottingham, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720675663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 12521 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspire Wellness Center Inc | 2961685706 | 24 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
The launch of the government's Information Strategy for health and social care contains positive improvements which should benefit patients, but it would need to be carefully implemented so it didn't jeopardise patient confidentiality, the BMA said today (Monday 21 May 2012).
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study.
Cell Therapeutics, Inc. announced today that, in a study from Brown University to be presented by Howard Safran, M.D., head of the Brown University Oncology Group, in the proffered oral session at the Annual Meeting of the International Society of Gastrointestinal Oncology (ISGIO) in Philadelphia, Pennsylvania patients with cancer of the lower esophagus demonstrated a high rate of complete remission (CR) when given OPAXIO(TM) (paclitaxel poliglumex), a biologically enhanced paclitaxel, when administered in combination with standard cisplatin and concurrent radiation.
ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.
› Verified 6 days ago
| Entity Name | Aspire Wellness Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780971630 PECOS PAC ID: 2961685706 Enrollment ID: O20110331000650 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
The launch of the government's Information Strategy for health and social care contains positive improvements which should benefit patients, but it would need to be carefully implemented so it didn't jeopardise patient confidentiality, the BMA said today (Monday 21 May 2012).
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study.
Cell Therapeutics, Inc. announced today that, in a study from Brown University to be presented by Howard Safran, M.D., head of the Brown University Oncology Group, in the proffered oral session at the Annual Meeting of the International Society of Gastrointestinal Oncology (ISGIO) in Philadelphia, Pennsylvania patients with cancer of the lower esophagus demonstrated a high rate of complete remission (CR) when given OPAXIO(TM) (paclitaxel poliglumex), a biologically enhanced paclitaxel, when administered in combination with standard cisplatin and concurrent radiation.
ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Winship Winship, LCSW-C 6 Gilland Ct, Nottingham, MD 21236-2901 Ph: (410) 746-5671 | Kimberly Winship Winship, LCSW-C 6 Gilland Ct, Nottingham, MD 21236-2901 Ph: (410) 746-5671 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).
The launch of the government's Information Strategy for health and social care contains positive improvements which should benefit patients, but it would need to be carefully implemented so it didn't jeopardise patient confidentiality, the BMA said today (Monday 21 May 2012).
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study.
Cell Therapeutics, Inc. announced today that, in a study from Brown University to be presented by Howard Safran, M.D., head of the Brown University Oncology Group, in the proffered oral session at the Annual Meeting of the International Society of Gastrointestinal Oncology (ISGIO) in Philadelphia, Pennsylvania patients with cancer of the lower esophagus demonstrated a high rate of complete remission (CR) when given OPAXIO(TM) (paclitaxel poliglumex), a biologically enhanced paclitaxel, when administered in combination with standard cisplatin and concurrent radiation.
ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.
› Verified 6 days ago
Ms. Margot Allen, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4308 Bedrock Cir Apt 101, Nottingham, MD 21236 Phone: 443-834-2306 | |
John A Lafferty, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8704 Blairwood Rd Apt B2, Nottingham, MD 21236 Phone: 202-683-0049 | |
Ms. Shanine A. Borum, LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 Bellfalls Way, Nottingham, MD 21236 Phone: 410-782-1888 | |
Rachel Matthews, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5022 Campbell Blvd # 4969, Nottingham, MD 21236 Phone: 443-442-1568 | |
Johanne Elaine Etienne Zawitoski, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9649 Belair Rd Ste 104, Nottingham, MD 21236 Phone: 410-529-1309 Fax: 410-529-1005 | |
Bailey Pararas, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9649 Belair Rd Ste 104, Nottingham, MD 21236 Phone: 410-529-1309 Fax: 410-529-1005 | |
Nicole Kafka, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7939 Honeygo Blvd Ste 224, Nottingham, MD 21236 Phone: 410-933-9700 |